MedTrace Logo

WORLD HEART FEDERATION (WHF) COVID-19 and Cardiovascular Disease Survey

NCT04475471 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 5200

Last updated 2023-01-27

No results posted yet for this study

Summary

A global study for a better understanding of the cardiovascular conditions that increase the risk of developing severe COVID-19, and a better characterization of cardiovascular complications in hospitalized patients with COVID-19.

Conditions

Sponsors & Collaborators

  • Centre for Chronic Disease Control, India

    collaborator OTHER

  • University of Cape Town

    collaborator OTHER

  • World Heart Federation, Geneva, Switzerland

    collaborator UNKNOWN

  • Public Health Foundation of India

    lead OTHER

Principal Investigators

  • KAREN SILWA, MD, PhD · University of Cape Town

  • Pablo PEREL, MD, PhD · London School of Hygiene and Tropical Medicine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-01
Primary Completion
2021-12-30
Completion
2023-12-31

Countries

  • Argentina
  • Bangladesh
  • Bosnia and Herzegovina
  • Colombia
  • Ghana
  • India
  • Iran
  • Japan
  • Kenya
  • Malaysia
  • Mexico
  • Nigeria
  • Pakistan
  • Portugal
  • South Africa
  • Sudan
  • Zambia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04475471 on ClinicalTrials.gov